There are many new molecular markers for the grade 3 anaplastic astrocytoma
that suggest that the outcomes may be improved.
One of the newest is the idh1/2 set of mutations. The astrocytomas that have these have a better response to the treatments and have a longer survival rate. There are new targeted therapies against the hedgehog genes that hold some promise. Keep watching for trials.